It’s the ‘closest thing to an HIV vaccine’, but who gets access?
Summary
A new injection given twice a year could change how HIV is prevented. However, there are big questions about who can get this drug because of issues with public funding, drug costs, and the power of pharmaceutical companies.Key Facts
- The injection is given twice a year to help prevent HIV infection.
- It is considered one of the most advanced HIV prevention methods.
- Access to the injection is a major concern worldwide.
- Public money and funding for global health are limited.
- Pharmaceutical companies have strong influence over drug prices and availability.
- There is a fight over how to make the injection affordable and accessible in different countries.
- The issue highlights larger problems about health funding and drug pricing.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
